borderline significanceP = .09
We observed that BMP4 treatment increased expression of LRP2 and CUBN ( P = .09, borderline significance), whereas AMN expression levels were unchanged (Figure 5 A‐C).
We observed that BMP4 treatment increased expression of LRP2 and CUBN ( P = .09, borderline significance), whereas AMN expression levels were unchanged (Figure 5 A‐C).